VESIcare Sales Data
| Rank 67 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows VESIcare U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 67 ( 4) |
$240,435 | 5.37% | 1,018 | 0.39% |
| Q3 2013 | 71 ( 2) |
$228,174 | 2.40% | 1,014 | -7.40% |
| Q2 2013 | 69 (1) |
$222,831 | 1.16% | 1,095 | -2.75% |
| Q1 2013 | 70 (7) |
$220,271 | 5.33% | 1,126 | 6.03% |
| Q4 2012 | 77 (2) |
$209,122 | 3.76% | 1,062 | 2.41% |
| Q3 2012 | 79 (7) |
$201,552 | 9.64% | 1,037 | 2.37% |
| Q2 2012 | 86 (9) |
$183,839 | 5.34% | 1,013 | 3.37% |
| Q1 2012 | 95 (5) |
$174,524 | 6.58% | 980 | 0.93% |
| Q4 2011 | 100 (1) |
$163,751 | 4.12% | 971 | 2.86% |
| Q3 2011 | 99 (2) |
$157,269 | -2.74% | 944 | -0.84% |
| Q2 2011 | 97 ( ) |
$161,704 | n/a | 952 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
